A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Public ClinicalTrials.gov record NCT03535194. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The reason for this study is to see how effective and safe mirikizumab is compared to secukinumab and placebo for moderate to severe plaque psoriasis.
Study identification
- NCT ID
- NCT03535194
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,484 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 26, 2018 (Actual)
- Primary completion
- Mar 5, 2020 (Actual)
- Completion
- Jun 3, 2020 (Actual)
- Last update posted
- Mar 30, 2021
2018 – 2020
United States locations
- U.S. sites
- 42
- U.S. states
- 22
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | — |
| Bakersfield Dermatology and Skin Cancer Medical Group | Bakersfield | California | 93309 | — |
| David Stoll, M.D. | Beverly Hills | California | 90212 | — |
| California Dermatology and Clinical Research Institute | Encinitas | California | 92024 | — |
| Tien Q. Nguyen, MD inc. DBA First OC Dermatology | Fountain Valley | California | 92708 | — |
| Keck School of Medicine University of Southern California | Los Angeles | California | 90033 | — |
| Dermatology Clinical Trials | Newport Beach | California | 92660 | — |
| San Luis Dermatology & Laser Clinic, Inc | San Luis Obispo | California | 93405 | — |
| Clinical Science Institute | Santa Monica | California | 90404 | — |
| Park Avenue Dermatology | Orange Park | Florida | 32073 | — |
| Dermatologic Surgery Specialists, PC | Macon | Georgia | 31217 | — |
| Medaphase Inc | Newnan | Georgia | 30263 | — |
| Meridian Clinical Research | Savannah | Georgia | 31406 | — |
| Treasure Valley Dermatology | Boise | Idaho | 83713 | — |
| University Dermatology | Darien | Illinois | 60561 | — |
| Arlington Dermatology | Rolling Meadows | Illinois | 60008 | — |
| Dawes Fretzin Clinical Research | Indianapolis | Indiana | 46250 | — |
| The Indiana Clinical Trials Center, PC | Plainfield | Indiana | 46168 | — |
| The South Bend Clinic | South Bend | Indiana | 46617 | — |
| Dermatology Specialist | Louisville | Kentucky | 40241 | — |
| DelRicht Research | Baton Rouge | Louisiana | 70809 | — |
| Dermatology and Skin Cancer Specialists | Rockville | Maryland | 20850 | — |
| Lawrence J Green, M.D, LLC | Rockville | Maryland | 20850 | — |
| ORA, Inc | Andover | Massachusetts | 01810 | — |
| Central Dermatology PC | St Louis | Missouri | 63117 | — |
| Psoriasis Treatment Center of Central New Jersey | East Windsor | New Jersey | 08520 | — |
| Mount Sinai School of Medicine Dermatology Clinical Trials | New York | New York | 10029 | — |
| PMG Research of Cary, LLC | Cary | North Carolina | 27511 | — |
| University of North Carolina Dermatology and Skin Cancer Cen | Chapel Hill | North Carolina | 27516 | — |
| PMG Research of Wilmington, LLC | Wilmington | North Carolina | 28401 | — |
| Bexley Dermatology Research | Bexley | Ohio | 43209 | — |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| Wright State Physicians Dermatology | Fairborn | Ohio | 46435 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Clinical Partners LLC | Johnston | Rhode Island | 02919 | — |
| Modern Research Associates PLLC | Dallas | Texas | 75231 | — |
| Austin Institute for Clinical Research, Inc. | Pflugerville | Texas | 78660 | — |
| Texas Dermatology and Laser Specialists | San Antonio | Texas | 78218 | — |
| Jordan Valley Dermatology Center | West Jordan | Utah | 84088 | — |
| Virginia Clinical Research | Norfolk | Virginia | 23502 | — |
| Dermatology Associates | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 136 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03535194, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 30, 2021 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03535194 live on ClinicalTrials.gov.